Vir Biotechnology stock has a bullish daily setup, but shorter-term signals are not unanimous. Price sits above the daily exponential averages and at the upper Bollinger band. The hourly chart supports the broader bias, while the 15-minute MACD leaves short-term confirmation incomplete.
VIR — daily chart with candlesticks, EMA20/EMA50 and volume.
Key takeaways
Vir Biotechnology stock closed at $12.21 on Friday, November 6, 2026, a gain of 10.8% versus the previous close of $11.02.
The daily close sits at the daily upper Bollinger band at $12.21.
The 20-session EMA at $11.22 stands above the 50-session EMA at $10.88 and the 200-session EMA at $9.56.
Daily RSI14 is 59.87, above 50 and below overbought, and the daily MACD line at 0.21 is above its signal at 0.13.
The next-session daily pivot is $11.98, with first resistance at $12.67 and first support at $11.52.
Vir Biotechnology stock daily chart structure
The daily chart supports a bullish bias for Vir Biotechnology stock, which closed Friday’s session at $12.21 . VIR opened at $11.30, traded between a low of $11.30 and a high of $12.45, and closed at $12.21, against a previous close of $11.02. The gain was 10.8% versus the November 5 close of $11.02, with volume of 1,895,300 shares.
Daily trend and momentum
The daily averages are bullishly aligned beneath the closing price. Its 20-session EMA stands at $11.22, above the 50-session EMA at $10.88 and the 200-session EMA at $9.56. This ordering supports the bullish thesis rather than merely placing price above an isolated average.
Meanwhile, daily RSI14 stands at 59.87, above 50 but below overbought territory. The MACD line is 0.21, above its signal at 0.13, with a positive histogram of 0.08. Both readings support the daily bias, without an overbought RSI reading.
Volatility and Bollinger band context
However, the close matches the daily upper Bollinger band at $12.21, placing price at the envelope’s upper boundary. Daily ATR14 increased to $0.71 from $0.65 on the preceding candle, indicating greater absolute price variability. That combination makes the bullish structure clear, but does not establish a breakout beyond the band.
Hourly and 15-minute signals
Shorter-term signals mostly reinforce the daily bias for Vir Biotechnology stock, while the 15-minute MACD remains below its signal. The hourly chart keeps bullishly aligned averages beneath the daily close.
Hourly trend structure
Its 20-hour EMA is $11.7, above the 50-hour EMA at $11.47 and the 200-hour EMA at $11.13. The close remains below the hourly upper Bollinger band at $12.44, leaving that boundary overhead.
Nevertheless, hourly RSI14 declined to 65.38 from 70.19 on the preceding candle. It is now below the overbought threshold, though still above 50. The hourly MACD histogram decreased to 0.1 from 0.11, but remains positive. Its line at 0.22 is above the signal at 0.11, so the hourly evidence still supports the daily view.
15-minute execution signals
In contrast, the 15-minute MACD line at 0.19 sits below its signal at 0.2, with a negative histogram of -0.01. RSI14 is 62.92, above 50, and the daily close sits above the 15-minute 20-period EMA at $12.08. These are mixed execution signals, not a bearish daily structure.
Hepatitis trial coverage adds later news context
Hepatitis trial reports appeared after Friday’s session. A report published on Saturday, November 7, 2026, said Vir Biotechnology would present primary endpoint data from its Phase 3 ECLIPSE 1 trial . The presentation concerns elebsiran and tobevibart for chronic hepatitis delta at the AASLD Liver Meeting 2026. Expanded Phase 2 SOLSTICE results and a call discussing topline findings were also planned.
Subsequently, a report published on Sunday, November 8, 2026, said the hepatitis delta combination met its Phase 3 goal. It also reported lasting viral suppression in Phase 2. Both reports appeared on later days than Friday’s session.
Next-session levels for Vir Biotechnology stock
For the next session, the daily pivot is $11.98, with first resistance at $12.67 and first support at $11.52. These levels derive from the completed daily candle.
Support and resistance levels
The bullish scenario requires holding above that pivot and clearing the daily upper band at $12.21, then Friday’s high at $12.45. A move through those levels would support a challenge of daily first resistance at $12.67.
For execution context when trading resumes, the hourly pivot is $12.25, above the daily close. The 15-minute pivot is $12.21, with first resistance at $12.28 and first support at $12.13. Clearing the hourly pivot and then 15-minute first resistance would strengthen short-term confirmation of the daily bullish case.
Conversely, a break below 15-minute first support at $12.13 would put the daily pivot at $11.98 in focus. Below that, daily first support at $11.52 becomes the next reference. A break beneath the daily 20-session EMA at $11.22 would invalidate the near-term bullish case built around support above the daily averages.
Overall, Vir Biotechnology stock stands at $12.21, on its daily upper Bollinger band and above the next-session daily pivot. Daily ATR14 at $0.71 frames the volatility risk. The unresolved question is whether short-term signals can confirm the bullish daily structure beyond the overhead levels.
FAQ
What does the daily chart show for Vir Biotechnology stock?
The daily chart supports a bullish bias. Vir Biotechnology stock closed at $12.21, above the 20-session EMA at $11.22, the 50-session EMA at $10.88, and the 200-session EMA at $9.56.
What are the key next-session levels?
The daily pivot is $11.98, with first resistance at $12.67 and first support at $11.52. The hourly pivot is $12.25, and the 15-minute pivot is $12.21, with first resistance at $12.28 and first support at $12.13.
What do the short-term indicators show?
Hourly RSI14 is 65.38, above 50, and the hourly MACD line at 0.22 is above its signal at 0.11. The 15-minute MACD line at 0.19 is below its signal at 0.2, with a negative histogram of -0.01.
How does the close compare with the daily Bollinger band?
The close matches the daily upper Bollinger band at $12.21, placing price at the envelope’s upper boundary.
{“@context”:”https://schema.org”,”@type”:”FAQPage”,”mainEntity”:[{“@type”:”Question”,”name”:”What does the daily chart show for Vir Biotechnology stock?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The daily chart supports a bullish bias. Vir Biotechnology stock closed at $12.21, above the 20-session EMA at $11.22, the 50-session EMA at $10.88, and the 200-session EMA at $9.56.”}},{“@type”:”Question”,”name”:”What are the key next-session levels?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The daily pivot is $11.98, with first resistance at $12.67 and first support at $11.52. The hourly pivot is $12.25, and the 15-minute pivot is $12.21, with first resistance at $12.28 and first support at $12.13.”}},{“@type”:”Question”,”name”:”What do the short-term indicators show?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”Hourly RSI14 is 65.38, above 50, and the hourly MACD line at 0.22 is above its signal at 0.11. The 15-minute MACD line at 0.19 is below its signal at 0.2, with a negative histogram of -0.01.”}},{“@type”:”Question”,”name”:”How does the close compare with the daily Bollinger band?”,”acceptedAnswer”:{“@type”:”Answer”,”text”:”The close matches the daily upper Bollinger band at $12.21, placing price at the envelope’s upper boundary.”}}]}
Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument. The analysis provided is not indicative of future results. Investing in financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.
Cryptonomist and the author hold no positions in the financial instruments mentioned and receive no compensation from the companies covered.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.
